Trials / Conditions / Adenocarcinoma Gastric
Adenocarcinoma Gastric
3 registered clinical trials studyying Adenocarcinoma Gastric.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Can NCT05071053 | Sanofi | Phase 2 |
| Completed | DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Prote NCT03368196 | Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company | Phase 1 |
| Completed | Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarci NCT03409848 | AIO-Studien-gGmbH | Phase 2 |